Are you sure you want to release this page to the administration? This action cannot be undone and you will lose ownership of the page.
Page successfully released to administration.
Error releasing page. Please try again later.
66310749bcfff12927ae17a5
Information
Paolo Di Giorgio
Dal 2022 guida Angelini Ventures con oltre 20 anni di esperienza in venture capital, R&D, business development in aziende come Angelini Pharma, Novartis e Merck. Ha conseguito un dottorato di ricerca all’Università di Harvard e un MBA all’IE business school.
